Search

everythinglearnresearchcommunity

for

Search:↓

Certain medications, especially 5-α reductase inhibitors and neuropsychiatric drugs, are often linked to erectile dysfunction.

Five-alpha reductase inhibitors, like finasteride and dutasteride, can treat enlarged prostates, improve urination, reduce need for prostate surgery, and lower the risk of prostate cancer, but may increase the risk of higher grade prostate cancer. They can also treat male pattern baldness.

Oral finasteride and dutasteride may negatively affect erectile function in rats.

Using finasteride for hair loss or prostate issues does not significantly raise the risk of erectile dysfunction.

5-alpha-reductase inhibitors might help slow down low-risk prostate cancer, but their use should be cautious.

5α-reductase inhibitors may help with prostate cancer but could increase the risk of severe tumors, so careful use is advised.

5-Alpha reductase inhibitors are safe long-term but may be outdated for preventing less significant prostate cancer.

5α-reductase inhibitors for hair loss can cause mild, reversible sexual side effects in some men.

Post-Finasteride Syndrome causes lasting sexual, mood, and metabolic issues, needing personalized treatment and better informed consent.

Most dermatologists think post-finasteride syndrome is rare, possibly psychiatric, and needs more research.

Finasteride improves prostate cancer prediction by adjusting kallikrein marker levels.

5-alpha reductase inhibitors slightly increase depression risk, but the risk varies based on the control group used.

Using 5-alpha reductase inhibitors may lower prostate cancer risk in people with androgenetic alopecia.

5-alpha reductase inhibitors do not increase osteoporosis risk in women with certain hair loss conditions.

Finasteride can cause melasma, especially in people with darker skin.

Finasteride can cause melasma, especially in people with darker skin.

Oral and topical 5-alpha reductase inhibitors affect DHT levels and hair density differently in treating hair loss.

Using 5-alpha reductase inhibitors may lower prostate cancer risk in people with androgenetic alopecia.

5-alpha reductase inhibitors may increase depression risk by 31%, but results vary based on comparison groups.

5α-reductase inhibitors help treat prostate enlargement and hair loss but may cause side effects, requiring careful use.

5α-reductase inhibitors effectively treat enlarged prostate and hair loss but require careful use due to possible side effects.

Higher doses of 5α-reductase inhibitors may lower mortality risk, but low doses increase it.

Higher doses of 5α-reductase inhibitors reduce mortality risk, while lower doses increase suicide risk.

Drugs for prostate enlargement and hair loss were not linked to increased risk of depression or suicide.

New treatments for male hair loss are being explored to improve effectiveness and reduce side effects.

Finasteride 5mg daily is the most effective for female pattern hair loss, with higher doses of treatments generally more effective.

5α-reductase inhibitors do not improve survival in oesophageal and gastric cancer patients.

5-alpha reductase inhibitors, like finasteride and dutasteride, are used for prostate issues, hair loss, and excessive hair growth, may help with COVID-19, but can cause sexual and mental health side effects, and their use in preventing prostate cancer needs more examination.

Certain medications, especially 5-alpha reductase inhibitors, are commonly linked to erectile dysfunction.

5-alpha reductase inhibitors may have additional effects on cancer, mental health, heart health, and hormone levels beyond treating prostate enlargement.